The import value for Medicaments for Therapeutic, Prophylactic Use, in Dosage to Indonesia stood at $739.18 million in 2023. The year-on-year variation showed a 3.39% increase from 2022, following a slight decline of -1.35% between 2021 and 2022. Over the last five years, the average annual growth rate (CAGR) was 3.92%. The forecast for the period from 2024 to 2028 predicts a relatively modest CAGR of 2.22%, reflecting slower growth trends but an overall 11.59% increase in import values by 2028, reaching $854.56 million.
Trends to watch for in the coming years include:
- Increased regulatory scrutiny and potential trade barriers that could impact supply chains.
- Growth in the domestic pharmaceutical industry which might reduce dependency on imports.
- Rising healthcare needs and spending due to an aging population and increased prevalence of chronic diseases.
- Innovation and introduction of new medicaments that could drive higher import values.
